Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cell lines.
Lindkvist A, Franzén A, Ren ZP, Heldin NE, Paulsson-Karlsson Y. Lindkvist A, et al. Biochem Biophys Res Commun. 2005 Dec 23;338(3):1625-33. doi: 10.1016/j.bbrc.2005.10.131. Epub 2005 Nov 2. Biochem Biophys Res Commun. 2005. PMID: 16288728
Interferon-induced sensitization to apoptosis is associated with repressed transcriptional activity of the hTERT promoter in multiple myeloma.
Lindkvist A, Ivarsson K, Jernberg-Wiklund H, Paulsson-Karlsson Y. Lindkvist A, et al. Biochem Biophys Res Commun. 2006 Mar 24;341(4):1141-8. doi: 10.1016/j.bbrc.2006.01.068. Epub 2006 Jan 26. Biochem Biophys Res Commun. 2006. PMID: 16460686
Telomerase activity is not a key determinant of sensitivity to standard cytotoxic drugs in human esophageal carcinoma cell lines.
Dreilich M, Lindkvist A, Dhar S, Paulsson-Karlsson Y, Brattström D, Nygren P, Rickardson L, Wagenius G, Bergqvist M. Dreilich M, et al. Among authors: lindkvist a. Anticancer Drugs. 2006 Jun;17(5):503-9. doi: 10.1097/00001813-200606000-00003. Anticancer Drugs. 2006. PMID: 16702806